A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
PharmacokineticsOpen LabelCAZ-AVICXLEffect on Intestinal FloraSafety
Interventions
DRUG

CAZ-AVI

IV infusion

DRUG

CXL

IV infusion

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY